These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30511543)

  • 1. Birth outcomes after inadvertent use of category X drugs contraindicated in pregnancy: Where is the real risk?
    Öztürk Z; Ölmez E; Gürpınar T; Vural K
    Turk J Pediatr; 2018; 60(3):298-305. PubMed ID: 30511543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development.
    Larsen AD
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
    Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M
    Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?
    Cunnington M; Ephross S; Churchill P
    Headache; 2009; 49(10):1414-22. PubMed ID: 19804390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A; Maciejewski T; Niemiec KT
    Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy.
    Namazy J; Cabana MD; Scheuerle AE; Thorp JM; Chen H; Carrigan G; Wang Y; Veith J; Andrews EB
    J Allergy Clin Immunol; 2015 Feb; 135(2):407-12. PubMed ID: 25441639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry.
    Shahir AK; Briggs N; Katsoulis J; Levidiotis V
    Nephrology (Carlton); 2013 Apr; 18(4):276-84. PubMed ID: 23441694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
    Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
    Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women referred for occupational risk assessment in pregnancy have no increased risk of adverse obstetric outcomes.
    Bidstrup SB; Kaerlev L; Thulstrup AM; Bonde JP
    Dan Med J; 2015 Aug; 62(8):A5119. PubMed ID: 26239590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment.
    Sinclair SM; Jones JK; Miller RK; Greene MF; Kwo PY; Maddrey WC
    Drug Saf; 2017 Dec; 40(12):1205-1218. PubMed ID: 28689333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes after maternal betahistine exposure: A case series.
    Buharalioglu CK; Acar S; Erol-Coskun H; Küçüksolak G; Karadas B; Kaya-Temiz T; Kaplan YC
    Reprod Toxicol; 2018 Aug; 79():79-83. PubMed ID: 29908288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.
    Carman WJ; Accortt NA; Anthony MS; Iles J; Enger C
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1109-1118. PubMed ID: 28758274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcomes after fetal exposure to antithyroid medications or levothyroxine.
    Schurmann L; Hansen AV; Garne E
    Early Hum Dev; 2016 Oct; 101():73-7. PubMed ID: 27416058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment.
    Winklbaur B; Baewert A; Jagsch R; Rohrmeister K; Metz V; Aeschbach Jachmann C; Thau K; Fischer G
    Eur Addict Res; 2009; 15(3):150-6. PubMed ID: 19420947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.